Devil in the detail: MET overexpression fails as surrogate marker for MET exon 14 splice site mutations in NSCLC

Lignende værker

• Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation
  af: Tanaka, Hisashi, et al.
  Udgivet: (2021)
• MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy
  af: Pilotto, Sara, et al.
  Udgivet: (2017)
• Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study
  af: Seto, Takashi, et al.
  Udgivet: (2021)
• Mutations at the splice sites of exon 14 of MET gene: a new target for sarcomatoid carcinomas?
  af: Wislez, Marie, et al.
  Udgivet: (2016)
• the devil is in the detail
  af: McKee, Martin, et al.
  Udgivet: (2004)